{"name":"Jerry R. Mendell","slug":"jerry-r-mendell","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"rAAV1.CMV.huFollistin344","genericName":"rAAV1.CMV.huFollistin344","slug":"raav1-cmv-hufollistin344","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"rAAV1.CMV.huFollistin344","genericName":"rAAV1.CMV.huFollistin344","slug":"raav1-cmv-hufollistin344","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9DMzlDbGdnWFZJSWxDQ3Vsa3k4Q3BxNHpVZ2NkM3k4eTNxd0FYYmF0Q3BYT0NiLXU5cndpQ09adGJnWjBlWFNUOHNTcVpvSTZTQnUxWk9oNzNSazNpUUpj?oc=5","date":"2024-10-09","type":"trial","source":"Nature","summary":"AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial - Nature","headline":"AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFBrMjlKamRYT0N6X0p1cHI1dzJpTXdENzZJQmVtMWhqRlJTUnVTMjhvX2w0cTZHSTlSZkdUQ1pFOGhaTEtoTU1LUXJYM01WRWs4dWx5eGk1QkhqWjV5WFcxWA?oc=5","date":"2017-11-02","type":"pipeline","source":"NEJM","summary":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy - NEJM","headline":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9rV1JoNlZqY29YOEJUNWw3WlVxQzdnUDBCT2RMeDFmWHdlNVc3TjYzTE04bmxaMGo1SEE2MHFaX1Vsc3F1RlVQRTNldUhKR2tVWC1XVThPTGtVcGJkX1RURg?oc=5","date":"2010-10-07","type":"pipeline","source":"NEJM","summary":"Dystrophin Immunity in Duchenne's Muscular Dystrophy - NEJM","headline":"Dystrophin Immunity in Duchenne's Muscular Dystrophy","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}